Eppich, S.; Kuhn, C.; Schmoeckel, E.; Mayr, D.; Mahner, S.; Jeschke, U.; Gallwas, J.; Heidegger, H.H.
MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas. Int. J. Mol. Sci. 2020, 21, 4529.
https://doi.org/10.3390/ijms21124529
AMA Style
Eppich S, Kuhn C, Schmoeckel E, Mayr D, Mahner S, Jeschke U, Gallwas J, Heidegger HH.
MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas. International Journal of Molecular Sciences. 2020; 21(12):4529.
https://doi.org/10.3390/ijms21124529
Chicago/Turabian Style
Eppich, Simon, Christina Kuhn, Elisa Schmoeckel, Doris Mayr, Sven Mahner, Udo Jeschke, Julia Gallwas, and Helene Hildegard Heidegger.
2020. "MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas" International Journal of Molecular Sciences 21, no. 12: 4529.
https://doi.org/10.3390/ijms21124529
APA Style
Eppich, S., Kuhn, C., Schmoeckel, E., Mayr, D., Mahner, S., Jeschke, U., Gallwas, J., & Heidegger, H. H.
(2020). MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas. International Journal of Molecular Sciences, 21(12), 4529.
https://doi.org/10.3390/ijms21124529